Isomil Post Marketing Observational Study

June 14, 2017 updated by: Melva Louisa

A Prospective, Open-label, Post-marketing Observational Study to Document the Use of Soy-based Infant Formula With Low Chain Polyunsaturates (LCP) in Infants With Symptoms Suggestive to Cow's Milk Allergy

The use of soy-isolate protein based formula for infants with cow's milk protein intolerance is common in Indonesia, however, there has not been any systematic collection of clinical data to determine the formula's gastrointestinal tolerance, and the parent's perceptions regarding the formula.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

534

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jakarta, Indonesia, 10430
        • Divisi Alergi Imunologi FKUI RSCM

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Infants with symptoms suggestive adverse reactions to cow's milk protein

Description

Inclusion Criteria:

  • infants of 6 - 12 months of age
  • full term infants
  • birth weight more than 2500 grams
  • infants developed symptoms suggestive adverse reactions to cow's milk protein in the investigator's clinical judgements
  • subject is prescribed a soy-based infant formula by physician

Exclusion Criteria:

  • established/suspected hypersensitivity fo soy
  • presence of adverse reactions to cow's milk caused by coincidental infections or other systemic disease
  • history of blood group incompatibility, premature delivery, HIV infections, major congenital abnormalities, systemic diseases
  • presence of severe gastrointestinal disorder
  • subject is participating in any interventional clinical study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Isomil Advance with LCP
4 spoonful of Isomil Advance with LCP in 240 mL of water, 4 times a day

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Parent's acceptance in the feeding of a soy-based infant formula with LCP in infants with symptoms suggestive adverse reactions to cow milk protein
Time Frame: 4-week
4-week

Secondary Outcome Measures

Outcome Measure
Time Frame
percentage of infants with gastrointestinal adverse events
Time Frame: 4-week
4-week
percentage of infants with adverse events
Time Frame: 4-week
4-week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Zakiudin Munasir, MD, PhD, Division of allergy and Immunology, Department of Child Health, Faculty of Medicine, Universitas Indonesia
  • Study Chair: Sumadiono, MD, PhD, RS Sardjito, Jl Kesehatan No 1 Yogyakarta
  • Study Chair: Anang Endaryanto, MD, PhD, Allergy Immunology Working Unit, East Java Branch of Indonesian Pediatric Society
  • Study Chair: Dina Muktiarti, MD, Sub Divisi Alergi Imunologi IKA FKUI, Jakarta
  • Study Chair: Dewi Kumara Wati, MD, PhD, RSUP Sanglah, Jl Kesehatan No 1-10 Denpasar Bali
  • Study Chair: Budi Setiabudiawan, MD, PhD, RS Hasan Sadikin Jl Pasteur No 38 Bandung

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2011

Primary Completion (Actual)

April 1, 2013

Study Completion (Actual)

July 1, 2013

Study Registration Dates

First Submitted

January 25, 2013

First Submitted That Met QC Criteria

March 11, 2013

First Posted (Estimate)

March 13, 2013

Study Record Updates

Last Update Posted (Actual)

June 16, 2017

Last Update Submitted That Met QC Criteria

June 14, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cow's Milk Allergy

3
Subscribe